NCT01576393

Brief Summary

Given the reciprocal nature of parent-child interaction, involvement of the adolescent in their mother's substance abuse treatment plan might be associated with reductions in adult relapse and improvements in child functioning. These findings would support the assertion that focus on family dynamics in substance abuse treatment programs is an effective use of resources and an important target of intervention efforts. One hundred eighty-three substance abusing mothers and their child (n=61 assigned to each condition) will receive treatment as usual (TAU) and be randomly assigned to 1) Ecologically-based family therapy (EBFT) conducted in the home or 2) Ecologically-based family therapy conducted at the treatment center, or 3) an attention control, Women's Health Education (WHE). In order to examine the endurance of treatment effects, this project will assess the parent and child at 3, 6, 12, and 18 months post-baseline. Hypotheses

  1. 1.It is expected that 1) mothers and children assigned to home and office based family therapy will show greater reductions in substance use and improvement in individual and family functioning at post-treatment compared to those in the attention control, and 2) those assigned to home-based family therapy will show greater reductions in substance use and improved individual and family functioning at post-treatment compared to those assigned to office-based family therapy.
  2. 2.It is expected that 1) those assigned to home or office based family therapy will continue to maintain improvements in substance use, individual and family domains over time (time by treatment interaction) compared to those assigned to the attention control and 2) those assigned to home-based family therapy will continue to maintain improvements in substance use, individual and family domains over time (time by treatment interaction) compared to those assigned to office-based family therapy.
  3. 3.It is hypothesized that improved family interaction skills will mediate substance use, individual and family outcomes.
  4. 4.It is expected that EBFT in the home and EBFT in the office will be more cost effective than TAU, and that EBFT in the home will be more cost effective than EBFT in the office

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
183

participants targeted

Target at P75+ for phase_1

Timeline
Completed

Started Aug 2009

Longer than P75 for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2009

Completed
2.7 years until next milestone

First Submitted

Initial submission to the registry

April 9, 2012

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 12, 2012

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2014

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2015

Completed
Last Updated

September 22, 2015

Status Verified

September 1, 2015

Enrollment Period

4.8 years

First QC Date

April 9, 2012

Last Update Submit

September 20, 2015

Conditions

Keywords

substance abusetreatmentfamilies

Outcome Measures

Primary Outcomes (1)

  • Substance use

    Change in frequency of reported substance use

    baseline, 3, 6, 12 and 18-months

Study Arms (3)

Home-Based family therapy

EXPERIMENTAL

12 home-based family therapy sessions

Behavioral: Home-based Family Therapy

Office-based family therapy

ACTIVE COMPARATOR

12 office-based family therapy sessions

Behavioral: office-based family therapy

Women's Health Education

PLACEBO COMPARATOR

12 womens's health education sessions

Behavioral: WHE

Interventions

12 home-based family therapy sessions

Also known as: home-based Ecologically-based Family therapy
Home-Based family therapy

12 office-based family therapy sessions

Also known as: Office-based Ecologically-based Family Therapy
Office-based family therapy
WHEBEHAVIORAL

12 Women's Health Education Sessions

Also known as: Women's Health Education Intervention
Women's Health Education

Eligibility Criteria

Age8 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Adult mothers seeking outpatient treatment for alcohol or drug abuse or dependence as measured using the computerized diagnostic interview schedule (CDIS; Shaffer, 1992), and who report substance use within the past 90 days
  • A child, between the ages of 8 to 16, lives with the mother at least 50% time over the prior 2 years or continuously for the 6 months prior to the assessment interview.
  • If more than one 8-16 year old lives in the home, the one with the greater problem severity will be included in the study. Substance use will be probed ("Have you ever used alcohol or drugs?"). If one youth answers yes, and the other answers no, the one who answers yes will be included. If both child answer "yes", then the Form 90 substance use section \[history and current pattern\] will be administered to each. The child who reports the more severe pattern and history of use \[age of onset, type of drug used, frequency of current use\] will be included. If neither youth reports using alcohol or drugs, then the Youth Self-Report (Achenbach \& Edelbrock, 1982) will be administered and the youth with the greater total problem score will be included.
  • Family lives within 60 miles of the treatment facility.
  • Child and adult agree to participate in the assessment and treatment intervention.

You may not qualify if:

  • \. Evidence of unremitted psychosis or other condition which would impair their ability to understand and participate in the intervention or consent for research participation (as determined by CDISC).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Ohio State University

Columbus, Ohio, 43081, United States

Location

MeSH Terms

Conditions

Substance-Related Disorders

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental Disorders

Study Officials

  • Natasha Slesnick, Ph.D.

    Ohio State University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 9, 2012

First Posted

April 12, 2012

Study Start

August 1, 2009

Primary Completion

May 1, 2014

Study Completion

April 1, 2015

Last Updated

September 22, 2015

Record last verified: 2015-09

Locations